Listen Live
Donate
 on air
Schedule

KCRW

Read & Explore

  • News
  • Entertainment
  • Food
  • Culture
  • Events

Listen

  • Live Radio
  • Music
  • Podcasts
  • Full Schedule

Information

  • About
  • Careers
  • Help / FAQ
  • Newsletters
  • Contact

Support

  • Become a Member
  • Become a VIP
  • Ways to Give
  • Shop
  • Member Perks

Become a Member

Donate to KCRW to support this cultural hub for music discovery, in-depth journalism, community storytelling, and free events. You'll become a KCRW Member and get a year of exclusive benefits.

DonateGive Monthly

Copyright 2026 KCRW. All rights reserved.

Report a Bug|Privacy Policy|Terms of Service|
Cookie Policy
|FCC Public Files

Back to To the Point

To the Point

Stem Cells and the Politics of Science and Religion

President Obama's director of the National Institutes of Health was approved by the Senate without objection, but is now cancelling stem cell research projects he approved, because a federal judge has ruled that they violate the intent of Congress.

  • rss
  • Share
By Warren Olney • May 12, 2014 • 1 min read

President Obama's director of the National Institutes of Health was approved by the Senate without objection, but is now cancelling stem cell research projects he approved, because a federal judge has ruled that they violate the intent of Congress. This week's New Yorker contains an extensive profile of Francis Collins, who brought the Human Genome Project to a successful conclusion, early and millions under budget, but now finds himself in an odd position, partly because he's a believing Christian. Peter Boyer wrote the story.

  • https://images.ctfassets.net/2658fe8gbo8o/AvYox6VuEgcxpd20Xo9d3/769bca4fbf97bf022190f4813812c1e2/new-default.jpg?h=250

    Warren Olney

    former KCRW broadcaster

  • KCRW placeholder

    Julia Flucht

    Producer, 'To the Point'

  • KCRW placeholder

    Christian Bordal

    Managing Producer, Greater LA

  • KCRW placeholder

    Peter Boyer

    Newsweek

    NewsNationalPolitics
Back to To the Point